RE:NewsSome good excerpts from Philip; "Understanding the coming revolution in cell therapy treatments of diabetes, a number of international pharmaceutical companies have advanced stem cell technologies but lack a medical device and immune protection to put it all together, making Sernovas proven technologies of great interest Philip Toleikis Dr. Toleikis contends that Sernovas Cell Pouch has solved issues of scalability, fibrosis, vascularization, cell engraftment, natural cell environment, biocompatibility and versatility through the use of human cells and tissue, as well as stem cell-derived islet cells. Anyways enough from me.